XML 29 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statement of Cash Flows - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net (loss) income $ (296.3) $ 231.9
Adjustments for:    
Depreciation and amortization 374.8 342.2
Impairment of goodwill 568.0 0.0
Impairment (reversal) of non-financial assets – net 57.3 (2.4)
Share of after-tax profit of equity accounted investees (72.2) (53.2)
Deferred income taxes (166.5) 10.4
Investment tax credits (14.8) (5.4)
Equity-settled share-based payments expense 14.8 6.1
Defined benefit pension plans 8.3 4.8
Other non-current liabilities (9.7) (15.9)
Derivative financial assets and liabilities – net (12.7) (3.7)
After-tax gain on disposal of discontinued operations (16.5) 0.0
Other 4.3 8.1
Changes in non-cash working capital 128.1 (114.5)
Net cash provided by operating activities 566.9 408.4
Investing activities    
Business combinations, net of cash acquired 0.0 (6.4)
Proceeds from disposal of discontinued operations 275.3 0.0
Property, plant and equipment expenditures (329.8) (268.8)
Proceeds from disposal of property, plant and equipment 4.0 5.7
Advance payments for property, plant and equipment 0.0 (30.1)
Intangible assets expenditures (147.9) (126.4)
Net payments to equity accounted investees (43.9) (10.9)
Dividends received from equity accounted investees 37.1 40.9
Other (10.2) (4.7)
Net cash used in investing activities (215.4) (400.7)
Financing activities    
Net (repayment of) proceeds from borrowing under revolving credit facilities (396.7) 44.5
Proceeds from long-term debt 433.5 31.2
Repayment of long-term debt (370.4) (161.0)
Repayment of lease liabilities (69.5) (83.4)
Net proceeds from the issuance of common shares 7.8 16.3
Other 0.0 (0.2)
Net cash used in financing activities (395.3) (152.6)
Effect of foreign currency exchange differences on cash and cash equivalents (13.7) 16.4
Net decrease in cash and cash equivalents (57.5) (128.5)
Cash and cash equivalents, beginning of year 217.6 346.1
Cash and cash equivalents, end of year $ 160.1 $ 217.6